You are here

Merck opens new S$20m lab offering biosafety testing services

BP_Merck_190918_4.jpg
Pharmaceutical firms in Asia can get quicker, more accessible testing services for their biological drug products from Merck's first BioReliance laboratory in the region, part of the pharmaceutical giant's new S$20 million, 3,800-square-metre facility in Singapore which was officially opened on Tuesday.

Singapore

PHARMACEUTICAL firms in Asia can get quicker, more accessible testing services for their biological drug products from Merck's first BioReliance laboratory in the region, part of the pharmaceutical giant's new S$20 million, 3,800-square-metre

sentifi.com

Market voices on: